Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Opelconazole

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pulmocide Ends OPERA-T Phase 3 Opelconazole Trial
    Pulmocide Ends OPERA-T Phase 3 Opelconazole Trial

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214562/0/en/Pulmocide-Announces-Termination-of-Opera-T-Phase-3-Study-with-Opelconazole.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Pulmocide OPERA-S Inhaled Opelconazole Phase 2 Positive Results
    Pulmocide OPERA-S Inhaled Opelconazole Phase 2 Positive Results

    15 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/15/2862691/0/en/Pulmocide-Announces-Successful-Results-from-the-OPERA-S-Study-a-Phase-2-Safety-Study-with-Inhaled-Opelconazole.html

    GLOBENEWSWIRE
    15 Apr 2024
    Share Share
    Pulmocide Announces Data Confirming Low Potential for Inhaled Opelconazole
    Pulmocide Announces Data Confirming Low Potential for Inhaled Opelconazole

    16 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/16/2760577/0/en/Pulmocide-Announces-New-Clinical-Data-Confirming-Low-Potential-for-Drug-Drug-Interactions-with-Inhaled-Opelconazole.html

    GLOBENEWSWIRE
    16 Oct 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.